Firm at a glance
Turenne Capital is a private equity firm, per its own website [S1].
What they buy
Based on publicly disclosed portfolio holdings, Turenne Capital appears to invest across a range of sectors including healthcare, technology, consumer, and industrial businesses [S1]. The firm’s portfolio includes medical device and diagnostic companies, software providers, specialty manufacturing operations, and consumer brands. The portfolio composition suggests a focus on European middle-market companies, though specific investment criteria are not publicly detailed.
Portfolio
Turenne Capital’s portfolio includes approximately 23 companies as of public sources [S1]:
Destia, Tampopo Group, 02D, Le Petit Souk, Kizeo, Groupe Colibri (Promesse de Fleurs), Ventuno Biotech, Kimialys, Lumen, Tallineau Emballage, TSA Industries, Le Bras Frères Agrotech, Mettetal Création, MIR (Medical International Research), VedaLab, Ô Voyages, SamanTree Medical SA, DeepLife, Finance Consult, SYDEV, ADVITAM PARTICIPATIONS, Greystal, and EDMI [S1].
Recent activity (last 24 months)
No recent public transactions were surfaced in the research conducted for this profile as of July 2026.
How this firm fits a seller
Turenne Capital may be suitable for owner-operators of middle-market businesses in healthcare, technology, consumer, or industrial sectors seeking a European-focused investor. The breadth of the portfolio suggests the firm is comfortable with diverse business models and end markets. Sellers in medical diagnostics, specialty manufacturing, software, or consumer products may find sector alignment with existing portfolio companies. Without recent public transaction data or detailed investment criteria, prospective sellers should verify current acquisition appetite and fit directly with the firm.
Sources
[S1] https://turennecapital.com (as of 2026-07-20)
Frequently asked questions
Does Turenne Capital buy healthcare businesses?
Yes, Turenne Capital’s portfolio includes multiple healthcare-related companies such as Ventuno Biotech, MIR (Medical International Research), VedaLab, and SamanTree Medical SA, per its website [S1]. The firm appears active in medical devices, diagnostics, and life sciences sectors based on these holdings.
What companies has Turenne Capital acquired recently?
Public sources as of July 2026 do not detail specific recent acquisitions. The firm’s disclosed portfolio includes companies such as Kizeo, Destia, and Finance Consult, though acquisition dates are not publicly available [S1].
Where is Turenne Capital based and how big is the firm?
The firm’s headquarters location, fund size, and assets under management are not disclosed in publicly available materials reviewed for this profile as of July 2026 [S1].
Is Turenne Capital still actively acquiring?
The firm maintains an active website listing portfolio companies [S1], though no transactions within the last 24 months were identified in public sources as of July 2026. Prospective sellers should contact the firm directly to confirm current acquisition activity.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.